Kazia Therapeutics Funding: $5.4M Raised, Series A (2019)
Kazia Therapeutics is based in Sydney, Australia. It has raised $5.4M in total funding. Latest round: Series A.
Kazia Therapeutics funding overview
Kazia Therapeutics is based in Sydney, Australia. Kazia Therapeutics has raised $5.4M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2019. The round record for Kazia Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Willoughby Capital, Quest Asset Partners, Platinum Asset Managers. 3 distinct backers are named across the disclosed rounds.
Kazia Therapeutics has raised $5.4M in total disclosed funding across the rounds on record.
Who has invested in Kazia Therapeutics?
Willoughby Capital, Quest Asset Partners, Platinum Asset Managers are named among the investors backing Kazia Therapeutics.
What was the latest Kazia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2019.
Where is Kazia Therapeutics based?
Kazia Therapeutics is based in Sydney, Australia.
When did Kazia Therapeutics last raise?
The last disclosed Kazia Therapeutics round closed in December 2019 at Series A.
Kazia Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Sydney below to benchmark round size and investor mix.
